$LTES
Leet Technology Inc

2024 Q3 Form 10-Q Financial Statement

#000168316824008004 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2023 Q3
Revenue $158.7K $34.29K
YoY Change 362.92% -32.94%
Cost Of Revenue $117.9K $155.3K
YoY Change -24.09% -28.37%
Gross Profit $40.83K -$121.0K
YoY Change -133.74% -26.97%
Gross Profit Margin 25.72% -352.97%
Selling, General & Admin $194.3K
YoY Change -44.82%
% of Gross Profit
Research & Development $9.173K $8.952K
YoY Change 2.47% -1.38%
% of Gross Profit 22.47%
Depreciation & Amortization $2.764K $2.800K
YoY Change -1.29% -75.5%
% of Gross Profit 6.77%
Operating Expenses $90.21K $203.2K
YoY Change -55.61% -43.73%
Operating Profit -$49.38K -$324.2K
YoY Change -84.77% -38.46%
Interest Expense $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $8.868K $16.87K
YoY Change -47.43% -103.58%
Pretax Income -$40.51K -$307.4K
YoY Change -86.82% -69.22%
Income Tax $21.00 $0.00
% Of Pretax Income
Net Earnings -$40.01K -$307.5K
YoY Change -86.99% -69.21%
Net Earnings / Revenue -25.21% -896.69%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 151.1M shares 151.1M shares
Diluted Shares Outstanding 151.1M shares 151.1M shares

Balance Sheet

Concept 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $14.85K
YoY Change 28.35%
Cash & Equivalents $13.80K $14.85K
Short-Term Investments
Other Short-Term Assets $12.59K
YoY Change -57.48%
Inventory
Prepaid Expenses
Receivables $321.6K $40.94K
Other Receivables $0.00
Total Short-Term Assets $370.4K $68.39K
YoY Change 441.61% -48.34%
LONG-TERM ASSETS
Property, Plant & Equipment $84.67K $109.6K
YoY Change -22.73% -8.63%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $84.67K $109.6K
YoY Change -22.73% -48.27%
TOTAL ASSETS
Total Short-Term Assets $370.4K $68.39K
Total Long-Term Assets $84.67K $109.6K
Total Assets $455.1K $178.0K
YoY Change 155.7% -48.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $62.31K $482.4K
YoY Change -87.08% -19.63%
Accrued Expenses $696.1K $200.3K
YoY Change 247.51% 249.67%
Deferred Revenue $0.00 $392.5K
YoY Change -100.0% 35.69%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.716M $3.709M
YoY Change 27.14% 123.78%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.716M $3.709M
Total Long-Term Liabilities $0.00
Total Liabilities $4.716M $3.709M
YoY Change 27.14% 123.78%
SHAREHOLDERS EQUITY
Retained Earnings -$12.56M -$11.99M
YoY Change 4.82% 18.66%
Common Stock $15.11K $15.11K
YoY Change 0.0% -1.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$10.19M -$9.092M
YoY Change
Total Liabilities & Shareholders Equity $455.1K $178.0K
YoY Change 155.7% -48.3%

Cashflow Statement

Concept 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$40.01K -$307.5K
YoY Change -86.99% -69.21%
Depreciation, Depletion And Amortization $2.764K $2.800K
YoY Change -1.29% -75.5%
Cash From Operating Activities -$305.0K
YoY Change -32.75%
INVESTING ACTIVITIES
Capital Expenditures -$30.00
YoY Change -118.75%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities $30.00
YoY Change -100.04%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 250.6K
YoY Change -36.95%
NET CHANGE
Cash From Operating Activities -305.0K
Cash From Investing Activities 30.00
Cash From Financing Activities 250.6K
Net Change In Cash -54.37K
YoY Change -60.76%
FREE CASH FLOW
Cash From Operating Activities -$305.0K
Capital Expenditures -$30.00
Free Cash Flow -$304.9K
YoY Change -32.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-480557 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
93682 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
40830 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
-121025 usd
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity Central Index Key
EntityCentralIndexKey
0001586495
CY2023Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
usd
CY2023Q2 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
usd
dei Entity File Number
EntityFileNumber
000-55053
dei Entity Registrant Name
EntityRegistrantName
LEET TECHNOLOGY INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-3590850
dei Entity Address Address Line1
EntityAddressAddressLine1
805, 8th Floor
dei Entity Address Address Line2
EntityAddressAddressLine2
Menara Mutiara Majestic
dei Entity Address Address Line3
EntityAddressAddressLine3
Jalan Othman, Petaling Jaya 46000
dei Entity Address City Or Town
EntityAddressCityOrTown
Selangor
dei Entity Address Country
EntityAddressCountry
MY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
00000
dei City Area Code
CityAreaCode
603
dei Local Phone Number
LocalPhoneNumber
7783 1636
dei Security12g Title
Security12gTitle
Common Stock Par value, $0.0001
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
151096262 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13804 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16580 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
321647 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16781 usd
CY2024Q3 us-gaap Deposits Assets Current
DepositsAssetsCurrent
34931 usd
CY2023Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
15036 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
370382 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
48397 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
84669 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
83932 usd
CY2024Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
84669 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
83932 usd
CY2024Q3 us-gaap Assets
Assets
455051 usd
CY2023Q4 us-gaap Assets
Assets
132329 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
62307 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
60378 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
696127 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
736212 usd
CY2024Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
353133 usd
CY2023Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
316471 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
313616 usd
CY2024Q3 LTES Due To Related Party Current
DueToRelatedPartyCurrent
3604224 usd
CY2023Q4 LTES Due To Related Party Current
DueToRelatedPartyCurrent
2629435 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4715791 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4056112 usd
CY2024Q3 us-gaap Liabilities
Liabilities
4715791 usd
CY2023Q4 us-gaap Liabilities
Liabilities
4056112 usd
CY2024Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
5945441 usd
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
5662325 usd
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
100 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
100 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
151096262 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
151096262 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
151096262 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
151096262 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
15110 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
15110 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2773081 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2773081 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-419676 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-32074 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12563494 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12334229 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-10194879 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-9578012 usd
CY2024Q3 us-gaap Minority Interest
MinorityInterest
-11302 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
-8096 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-10206181 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-9586108 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
455051 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
132329 usd
CY2024Q3 us-gaap Revenues
Revenues
158727 usd
CY2023Q3 us-gaap Revenues
Revenues
34288 usd
us-gaap Revenues
Revenues
703045 usd
us-gaap Revenues
Revenues
179424 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
117897 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
155313 usd
us-gaap Cost Of Revenue
CostOfRevenue
433432 usd
us-gaap Cost Of Revenue
CostOfRevenue
457209 usd
us-gaap Gross Profit
GrossProfit
269613 usd
us-gaap Gross Profit
GrossProfit
-277785 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9173 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8952 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
27104 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
26890 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
81033 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
194264 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
327712 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
847193 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
90206 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
203216 usd
us-gaap Operating Expenses
OperatingExpenses
354816 usd
us-gaap Operating Expenses
OperatingExpenses
874083 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-49376 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-324241 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-85203 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1151868 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
-0 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
-0 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
-0 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
5546 usd
CY2024Q3 LTES Recovery Written Off Of Accounts Receivable
RecoveryWrittenOffOfAccountsReceivable
0 usd
CY2023Q3 LTES Recovery Written Off Of Accounts Receivable
RecoveryWrittenOffOfAccountsReceivable
418 usd
LTES Recovery Written Off Of Accounts Receivable
RecoveryWrittenOffOfAccountsReceivable
0 usd
LTES Recovery Written Off Of Accounts Receivable
RecoveryWrittenOffOfAccountsReceivable
-32365 usd
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
66 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
1877 usd
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
4312 usd
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
17114 usd
CY2024Q3 LTES Cybersecurity Service Income
CybersecurityServiceIncome
-28651 usd
CY2023Q3 LTES Cybersecurity Service Income
CybersecurityServiceIncome
14501 usd
LTES Cybersecurity Service Income
CybersecurityServiceIncome
100 usd
LTES Cybersecurity Service Income
CybersecurityServiceIncome
29403 usd
CY2024Q3 LTES Loss On Early Redemption Of Convertible Promissory Note
LossOnEarlyRedemptionOfConvertiblePromissoryNote
-0 usd
CY2023Q3 LTES Loss On Early Redemption Of Convertible Promissory Note
LossOnEarlyRedemptionOfConvertiblePromissoryNote
-0 usd
LTES Loss On Early Redemption Of Convertible Promissory Note
LossOnEarlyRedemptionOfConvertiblePromissoryNote
-0 usd
LTES Loss On Early Redemption Of Convertible Promissory Note
LossOnEarlyRedemptionOfConvertiblePromissoryNote
28340 usd
CY2024Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
37453 usd
CY2023Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
73 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
130610 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
42578 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8868 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
16869 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
135022 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
22844 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-40508 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-307372 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
49819 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1129024 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-40529 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-307372 usd
us-gaap Profit Loss
ProfitLoss
49798 usd
us-gaap Profit Loss
ProfitLoss
-1129024 usd
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-516 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
85 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-4053 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-4193 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-40013 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-307457 usd
us-gaap Net Income Loss
NetIncomeLoss
53851 usd
us-gaap Net Income Loss
NetIncomeLoss
-1124831 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-386755 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
120459 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-521086 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-213690 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-336957 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1008565 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
151096262 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
151096262 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
151096262 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
151096262 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
151096262 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
151096262 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
151787179 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
151787179 shares
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-7807372 usd
CY2023Q1 us-gaap Dividends
Dividends
94372 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-5956 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-510821 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-8418521 usd
CY2023Q2 us-gaap Dividends
Dividends
94372 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
32733 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-310831 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-8790991 usd
CY2023Q3 us-gaap Dividends
Dividends
94372 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
93682 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-307372 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-9099053 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-9586108 usd
CY2024Q1 us-gaap Dividends
Dividends
94372 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
75808 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-123070 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-9727742 usd
CY2024Q2 us-gaap Dividends
Dividends
94372 usd
CY2024Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
17994 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
213397 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-9590723 usd
CY2024Q3 us-gaap Dividends
Dividends
94372 usd
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-480557 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-40529 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-10206181 usd
us-gaap Profit Loss
ProfitLoss
49798 usd
us-gaap Profit Loss
ProfitLoss
-1129024 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7983 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8519 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2525 usd
LTES Amortization Noncash Financing Cost
AmortizationNoncashFinancingCost
0 usd
LTES Amortization Noncash Financing Cost
AmortizationNoncashFinancingCost
3020 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
32364 usd
LTES Loss On Early Redemption Of Convertible Promissory Note
LossOnEarlyRedemptionOfConvertiblePromissoryNote
0 usd
LTES Loss On Early Redemption Of Convertible Promissory Note
LossOnEarlyRedemptionOfConvertiblePromissoryNote
28340 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
275912 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-77784 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
16129 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
1665 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4522 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-15734 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-101721 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-191032 usd
LTES Increase Decrease In Accrued Compensation Payable To Officers And Directors
IncreaseDecreaseInAccruedCompensationPayableToOfficersAndDirectors
0 usd
LTES Increase Decrease In Accrued Compensation Payable To Officers And Directors
IncreaseDecreaseInAccruedCompensationPayableToOfficersAndDirectors
10728 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-310934 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
144042 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-651437 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1030133 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1973 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1973 usd
LTES Proceeds From Repayments Of Director
ProceedsFromRepaymentsOfDirector
9715 usd
LTES Proceeds From Repayments Of Director
ProceedsFromRepaymentsOfDirector
830 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
627418 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
1169678 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
-0 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
113300 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
637133 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1057208 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11530 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-47059 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2776 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-21957 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16580 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36808 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13804 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14851 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13804 usd
CY2024Q3 LTES Working Capital Deficit
WorkingCapitalDeficit
-4345409 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12563494 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_844_eus-gaap--UseOfEstimates_znxhyRVKuTO3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span id="xdx_86C_z34GcOJMqYDg">Use of estimates and assumptions</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In preparing these unaudited condensed consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements during the period reported. Actual results may differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2024Q3 us-gaap Revenues
Revenues
158727 usd
CY2023Q3 us-gaap Revenues
Revenues
34288 usd
us-gaap Revenues
Revenues
703045 usd
us-gaap Revenues
Revenues
179424 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
183345 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
164311 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
98676 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
80379 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
84669 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
83932 usd
CY2024Q3 us-gaap Depreciation
Depreciation
2764 usd
CY2023Q3 us-gaap Depreciation
Depreciation
2802 usd
us-gaap Depreciation
Depreciation
7983 usd
us-gaap Depreciation
Depreciation
8519 usd
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
151096262 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
151096262 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
151096262 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
151096262 shares
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-40013 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-307457 usd
us-gaap Net Income Loss
NetIncomeLoss
53851 usd
us-gaap Net Income Loss
NetIncomeLoss
-1124831 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
151096262 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
151096262 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
151096262 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
151096262 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
151096262 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
151096262 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
151787179 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
151787179 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q3 LTES Due To Related Party Current And Noncurrent
DueToRelatedPartyCurrentAndNoncurrent
3604224 usd
CY2023Q4 LTES Due To Related Party Current And Noncurrent
DueToRelatedPartyCurrentAndNoncurrent
2629435 usd
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
0 usd
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
50845 usd
CY2023Q4 us-gaap Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
3152 usd
us-gaap Revenues
Revenues
703045 usd
us-gaap Cost Of Revenue
CostOfRevenue
433432 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
7983 usd
us-gaap Profit Loss
ProfitLoss
49798 usd
LTES Total Assets
TotalAssets
455051 usd
us-gaap Revenues
Revenues
179424 usd
us-gaap Cost Of Revenue
CostOfRevenue
457209 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
14064 usd
us-gaap Profit Loss
ProfitLoss
-1129024 usd
LTES Total Assets
TotalAssets
177966 usd
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001683168-24-008004-index-headers.html Edgar Link pending
0001683168-24-008004-index.html Edgar Link pending
0001683168-24-008004.txt Edgar Link pending
0001683168-24-008004-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
leet_ex3101.htm Edgar Link pending
leet_ex3102.htm Edgar Link pending
leet_ex3201.htm Edgar Link pending
leet_ex3202.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
leet_i10q-93024.htm Edgar Link pending
logo.jpg Edgar Link pending
ltes-20240930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
ltes-20240930_def.xml Edgar Link unprocessable
leet_i10q-93024_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ltes-20240930_cal.xml Edgar Link unprocessable
ltes-20240930_pre.xml Edgar Link unprocessable
ltes-20240930_lab.xml Edgar Link unprocessable